1. Jaradat, Jaber H, Idrissi, Yassine Alami, Saeed, Anwaar. . HOOK3 Amplification in Bladder Urothelial Carcinoma: Insights from Gene Expression and Survival Analysis. In Anticancer research, 44, 5175-5185. doi:10.21873/anticanres.17343. https://pubmed.ncbi.nlm.nih.gov/39626914/
2. Jin, Yongping, Ni, Shimao. 2019. miR-496 remedies hypoxia reoxygenation-induced H9c2 cardiomyocyte apoptosis via Hook3-targeted PI3k/Akt/mTOR signaling pathway activation. In Journal of cellular biochemistry, 121, 698-712. doi:10.1002/jcb.29316. https://pubmed.ncbi.nlm.nih.gov/31436348/
3. Sun, Tingting, Chen, Jing, Sun, Xuechao, Wang, Guonian. 2021. Midazolam increases cisplatin-sensitivity in non-small cell lung cancer (NSCLC) via the miR-194-5p/HOOK3 axis. In Cancer cell international, 21, 401. doi:10.1186/s12935-021-02104-6. https://pubmed.ncbi.nlm.nih.gov/34321010/
4. Melling, Nathaniel, Harutyunyan, Levon, Hube-Magg, Claudia, Schlomm, Thorsten, Krech, Till. 2015. High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate Cancer. In PloS one, 10, e0134614. doi:10.1371/journal.pone.0134614. https://pubmed.ncbi.nlm.nih.gov/26230842/
5. Kaiser, Frank, Kaufmann, Stefan H E, Zerrahn, Jens. 2004. IIGP, a member of the IFN inducible and microbial defense mediating 47 kDa GTPase family, interacts with the microtubule binding protein hook3. In Journal of cell science, 117, 1747-56. doi:. https://pubmed.ncbi.nlm.nih.gov/15075236/
智鼠故事 
